Yaroslau Compta

Sobre mi

Publicacions destacades

• Association of PSP phenotypes with survival: A brain-bank study

  Autors:

  Guasp, M; Molina-Porcel, L; Painous, C; Caballol, N; Camara, A;

  (...)

  Grau, O; Gelpí, E; Respondek, G; Höglinger, GH; Compta, Y.

  Veure llistat complet d'autors

  Referència: Parkinsonism & Related Disorders 2021.

• Neuropathological and Biomarker Findings in Parkinson's Disease and Alzheimer's Disease: From Protein Aggregates to Synaptic Dysfunction

  Autors:

  Compta, Y; Revesz, T;

  Referència: Journal Of Parkinsons Disease 2021.

• Prediagnostic motor and non-motor symptoms in progressive supranuclear palsy: The step-back PSP study

  Autors:

  Painous, Celia; Marti, Maria J; Simonet, Cristina; Garrido, Alicia; Valldeoriola, Francesc;

  Munoz, Esteban; Camara, Ana; Compta, Yaroslau.

  Referència: Parkinsonism & Related Disorders 2020.

• Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.

  Autors:

  Höglinger GU; Respondek G; Stamelou M; Kurz C; Josephs KA;

  (...)

  Wenning GK; Boxer AL; Golbe LI; Litvan I; Movement Disorder Society-endorsed PSP Study Group.

  Veure llistat complet d'autors

  Referència: Movement Disorders 2017.

• Correlates of cerebrospinal fluid levels of oligomeric-and total-α-synuclein in premotor, motor and dementia stages of Parkinson’s disease

  Autors:

  Compta Y; Valente T; Saura J; Segura B; Iranzo A;

  (...)

  Fortea J; Buongiorno M; Molinuevo JL; Bargallo N; Marti MJ.

  Veure llistat complet d'autors

  Referència: Journal Of Neurology 2015.

• Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study

  Autors:

  Compta, Yaroslau; Pereira, Joana B; Rios, Jose; Ibarretxe-Bilbao, Naroa; Junque, Carme;

  (...)

  Camara, Ana; Buongiorno, Mariateresa; Fernandez, Manel; Pont-Sunyer, Claustre; Marti, Maria J.

  Veure llistat complet d'autors

  Referència: Parkinsonism & Related Disorders 2013.

• Lewy- and Alzheimer-type pathologies in Parkinson''s disease dementia: which is more important?

  Autors:

  Parkkinen, Laura; O'Sullivan, Sean S; Vandrovcova, Jana; Holton, Janice L; Collins, Catherine;

  (...)

  Kallis, Constantinos; Williams, David R; de Silva, Rohan; Lees, Andrew J; Revesz, Tamas.

  Veure llistat complet d'autors

  Referència: Brain 2011.

• Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia

  Autors:

  Compta, Yaroslau; Santamaria, Joan; Ratti, Luca; Tolosa, Eduardo; Iranzo, Alex;

  Munoz, Esteban; Valldeoriola, Francesc; Casamitjana, Roser; Rios, Jose; Marti, Maria J.

  Referència: Brain 2009.

• Cerebrospinal Tau, Phospho-Tau, and Beta-Amyloid and Neuropsychological Functions in Parkinson's Disease

  Autors:

  Compta, Yaroslau; Marti, Maria J; Ibarretxe-Bilbao, Naroa; Junque, Carme; Valldeoriola, Francesc;

  Munoz, Esteban; Ezquerra, Mario; Rios, Jose; Tolosa, Eduardo.

  Referència: Movement Disorders 2009.

Projectes destacats

• Clinical Cohort study with biomarkers study of prediagnostic cases and health education program in established disease..

  Investigador/a principal: Yaroslau Compta Hirnyi

  Finançador: La MARATO - TV3

  Codi: 202009-10_PSP REGISTRY

  Durada: 12/03/2020 - 29/03/2024

• Amplificación de autoagregación de alfa-sinucleína y 4R-tau en tejido cerebral y líquido cerebrospinal mediante RTQuIC como biomarcador diferencial de parkinsonismos degenerativos.

  Investigador/a principal: Yaroslau Compta Hirnyi

  Finançador: ISCIII

  Durada: 01/01/2018 - 31/10/2021

• FAIR-PARK-II A multicentre, parallel group, randomized, placebo-controlled trial of deferiprone (DFP) 15 mg/kg BID

  Investigador/a principal: Yaroslau Compta Hirnyi

  Finançador: H2020, European Comission

  Durada: 05/01/2016 - 01/12/2021